The Pharmaceutical Benefits Advisory Committee will consider new proposals from MSD and Bristol Myers Squibb at its July meeting to accelerate reimbursement of approved indications for their immunotherapies. …
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Mesoblast updates investors on the succesful US launch of cell medicine
July 20, 2025 - - Australian Biotech -
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast -
Another day, another confusing response to the threat of US tariffs
July 17, 2025 - - Latest News -
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News